Unlike other groups, treatment with gentamicin during Salmonella infection does not lead to inflammatory metabolic responses (increased glycolysis or pentose phosphate shunt), increased ROS as indicated by increased catalase activity (data not shown) and decreased HIF-1α and NOS, or heightened energy requirement supported by both kinome and seahorse metabolic flux data (Figure 1 and Figure 4a). This evidence concerns the gene NOS2 and Salmonella Infections.